医療における人工知能のヨーロッパ市場2020-2115

◆英語タイトル:EUROPE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FORECAST 2020-2028
◆商品コード:INK20MY166
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年4月
◆ページ数:152
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe Europe artificial intelligence in healthcare market is projected to record growth, recording a CAGR of 35.45% during the forecast period, 2020-2028. There is increasing use of big data in healthcare by the biotechnology and pharmaceutical companies for integrating huge amounts of medical research and development data into the medical databases. This is the primary factor driving the growth of the market in the region.

REGIONAL INSIGHTS
The countries analyzed for market growth in the Europe artificial intelligence in healthcare market are the United Kingdom, Poland, Belgium, Russia, France, Germany, Italy, and the rest of Europe. In the UK, the growing importance of precision medicine and the rising use of big data in healthcare industry, are the key drivers of market growth. The pharmaceutical companies in the region have been gathering a considerable amount of research and development related data in medical databases. The UK government is collecting healthcare information form healthcare organizations like hospitals and clinics. The increasing healthcare expenditure has led to the deployment of big data. The healthcare providers in the UK are implementing AI in healthcare for analyzing the conditions of the patients, along with the systematic analysis of clinical data, so as to make optimal and cost-effective decisions regarding the treatment of patients. The big data tools in healthcare provide a unit-price discount facility that is based on contracting and negotiating leverage. AI is also used in genomic data analysis for the precise delivery of precision medicine. Precision medicine research aids the doctors in deploying the genetic and other molecular details of patients for predicting the best and cost-effective treatment.

COMPETITIVE INSIGHTS
Some of the renowned registering their presence in the market are, NVidia Corporation, Microsoft Corporation, Oncora Medical, Intel Corporation, Next It Corporation, ICarbonX, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. DEVELOPMENT OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. RISE OF BIG DATA IN HEALTHCARE INDUSTRY
3.3.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
3.3.3. INCREASING USE OF AI IN GENETICS
3.3.4. AI CREATING A REAL-TIME MONITORING SYSTEM
3.3.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
3.4. KEY RESTRAINTS
3.4.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
3.4.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
3.4.3. CHALLENGE TO MAINTAIN DATA SECURITY
3.4.4. LACK OF USABLE DATA IN HEALTHCARE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. VALUE CHAIN ANALYSIS
4.5.1. DATA WAREHOUSE
4.5.2. ARTIFICIAL INTELLIGENCE (AI) ANALYSIS
4.5.3. SOFTWARE DEVELOPMENT
4.6. KEY BUYING CRITERIA
4.6.1. APPLICATION
4.6.2. TECHNOLOGY
4.6.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
4.7. REGULATORY FRAMEWORK
5. MARKET BY OFFERINGS
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES
6. MARKET BY TECHNOLOGY
6.1. DEEP LEARNING
6.2. QUERYING METHOD
6.3. NATURAL LANGUAGE PROCESSING
6.4. CONTEXT AWARE PROCESSING
7. MARKET BY END-USER
7.1. ACOS AND MCOS
7.2. PATIENTS
7.3. PAYERS
7.4. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.5. PROVIDERS
8. MARKET BY APPLICATION
8.1. REAL-TIME MONITORING
8.2. PRECISION MEDICINE
8.3. PERSONAL HEALTH AND NURSING ASSISTANTS
8.4. DRUG DEVELOPMENT AND DISCOVERY
8.5. ROBOT-ASSISTED SURGERY
8.6. ADMINISTRATIVE WORKFLOW ASSISTANCE
8.7. CLINICAL TRIALS
8.8. DIAGNOSTIC AND CLINICAL DECISION SUPPORT
8.9. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. UNITED KINGDOM
9.1.2. GERMANY
9.1.3. FRANCE
9.1.4. ITALY
9.1.5. RUSSIA
9.1.6. BELGIUM
9.1.7. POLAND
9.1.8. REST OF EUROPE
10. COMPANY PROFILES
10.1. DEEP GENOMICS INC
10.2. ENLITIC INC
10.3. GE HEALTHCARE
10.4. GENERAL VISION INC
10.5. GOOGLE
10.6. IBM CORPORATION
10.7. ICARBONX
10.8. INTEL CORPORATION
10.9. MICROSOFT CORPORATION
10.10. NEXT IT CORPORATION
10.11. NVIDIA CORPORATION
10.12. ONCORA MEDICAL
10.13. RECURSION PHARMACEUTICALS INC
10.14. STRYKER CORPORATION
10.15. WELLTOK INC



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[医療における人工知能のヨーロッパ市場2020-2115]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆